Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Renapharma

Renapharma?uq=x1rNslWr
2000 FOUNDED
M&A STATUS
2ndary - Private LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Provider of iron medicines intended to improve patient's every day life. The company's iron medicines combine scientific knowledge and innovative technology, enabling patients to treat Vitamin D deficiency, particularly in indication groups for nephrology, gastroenterology and internal medicine. It also provides an application through which user can get reminders about their doses and record adherence to treatment.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Application Software
Parent Company
Primary Office
  • P.O. Box 938
  • 751 09 Uppsala
  • Sweden

+46 018-700 00 00

Renapharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Renapharma‘s full profile, request access.

Request full access to PitchBook

Renapharma Executive Team (1)

Name Title Board
Seat
Contact
Info
Bo Danielson Ph.D Founder